Kane Biotech (CVE:KNE) Stock Price Up 16.7% – Here’s What Happened

by · The Markets Daily

Kane Biotech Inc. (CVE:KNE – Get Free Report)’s share price was up 16.7% during trading on Wednesday . The stock traded as high as C$0.05 and last traded at C$0.04. Approximately 1,498,050 shares traded hands during mid-day trading, an increase of 1,131% from the average daily volume of 121,683 shares. The stock had previously closed at C$0.03.

Kane Biotech Trading Down 12.5%

The business has a 50 day simple moving average of C$0.03 and a 200-day simple moving average of C$0.04. The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42. The stock has a market capitalization of C$5.86 million, a price-to-earnings ratio of -0.44 and a beta of 0.29.

About Kane Biotech

(Get Free Report)

Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.

Featured Articles